artenimol has been researched along with Squamous Cell Carcinoma of Head and Neck in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, X; Lu, X; Sun, Y | 1 |
| Deng, Y; Wu, R; Zhang, Q; Zheng, S | 1 |
| Bao, B; Cheng, B; Hu, R; Ji, Y; Li, X; Liao, G; Luo, H; Ouyang, H; Shi, S; Wang, L; Wang, X; Wang, Y; Wang, Z; Xia, J; Xu, B | 1 |
| Li, X; Li, Z; Lu, X; Shi, X; Sun, Y; Wang, W | 1 |
| Li, H; Li, X; Li, Z; Shi, X; Sun, Y | 1 |
5 other study(ies) available for artenimol and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Dihydroartemisinin inhibits IL-6-induced epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway.
Topics: Artemisinins; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; MicroRNAs; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2021 |
Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Topics: Artemisinins; Biomarkers, Tumor; Calcium Channels; Calcium-Binding Proteins; Cation Transport Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2022 |
Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Mice; Mitochondria; Mouth Neoplasms; Oxidative Stress; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2023 |
Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.
Topics: Animals; Artemisinins; Cell Proliferation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplastic Stem Cells; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
Effects of magnetic dihydroartemisinin nano-liposome in inhibiting the proliferation of head and neck squamous cell carcinomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Proliferation; Drug Delivery Systems; Humans; Liposomes; Magnetics; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2019 |